Showing 7,881 - 7,900 results of 18,038 for search 'significantly ((((((we decrease) OR (largest decrease))) OR (teer decrease))) OR (a decrease))', query time: 0.47s Refine Results
  1. 7881
  2. 7882
  3. 7883
  4. 7884

    Table1_Comparative study on pregnancy complications: PGT-A vs. IVF-ET with gender-specific outcomes.docx by Ling Guo (9700)

    Published 2024
    “…In summary, PGT-A was associated with a decreased risk of maternal preeclampsia in singleton pregnancies with male fetuses, highlighting its potential utility in preeclampsia prevention in addition to spontaneous abortion rate reduction.…”
  5. 7885
  6. 7886
  7. 7887
  8. 7888
  9. 7889
  10. 7890
  11. 7891
  12. 7892

    Data Sheet 1_Treatment of bacterial biothreat agents with a novel purified bioactive lactoferrin affects both growth and biofilm formation.docx by Christian Xander (9120108)

    Published 2025
    “…Here, we show that Lactea Lf can significantly inhibit biofilm and decrease the overall growth in a dose dependent manner for all Burkholderia species tested. …”
  13. 7893
  14. 7894

    Acoustic startle at 6 dpf. by Morgan Barnes (7876373)

    Published 2025
    “…An unpaired t-test was used for all groups exhibiting normality except for when variances were significantly different (SLC-48). For those we utilized a Welch’s t-test. …”
  15. 7895
  16. 7896
  17. 7897

    Table 1_The association between a dietary index for the gut microbiota and frailty in older adults: emphasising the mediating role of inflammatory indicators.docx by Huangyi Yin (18593848)

    Published 2025
    “…After adjusting for all of the covariates, each unit increase in the DI-GM was associated with a 6% decrease in the prevalence of frailty (OR = 0.94; 95% CI: 0.89, 0.99; p = 0.020). …”
  18. 7898
  19. 7899
  20. 7900

    Discovery of MKP10241, a Novel Small Molecule Targeting the GPR119/Incretin Axis to Treat Metabolic Disorders by Santosh Kumar Rai (22382996)

    Published 2025
    “…We have developed a potent GPR119 agonist, MKP10241, which has elevated cyclic adenosine monophosphate (cAMP) levels in the GPR119 expressing cell line and reduced blood glucose levels and HbA1c in acute models and a chronic diabetic mouse model. …”